N-((1-(2-(tert-ButylaMino)-2-oxoethyl)piperidin-4-yl)Methyl)-3-chloro-5-fluorobenzaMide Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Z944 is an inhibitor of T-type calcium channels (IC
50s = 0.050-0.160 μM for the human recombinant voltage-gated calcium (Ca
v) channels Ca
v3.1, Ca
v3.2, and Ca
v3.3). It is selective for T-type channels over the N-type Ca
v2.2 channel (IC
50 = 11 μM), as well as the rat L-type Ca
v1.2, human-ether-a-go-go (hERG/K
v11.1) potassium, and human voltage-gated sodium (Na
v) channel Na
v1.5 (IC
50s = 32, 7.8, and 100 μM, respectively). Z944 (30 mg/kg) reduces the seizure duration and the amount of time rats spend in seizures in a model of absence epilepsy. It delays seizure progression in amygdala-kindled rats but does not inhibit seizures in fully kindled rats.
Chemische Eigenschaften
White Solid
Verwenden
As N-Piperidinyl acetamide derivatives, N-((1-(2-(tert-ButylaMino)-2-oxoethyl)piperidin-4-yl)Methyl)-3-chloro-5-fluorobenzaMide can be used as calcium channel blockers and their use in the treatment of obesity.
N-((1-(2-(tert-ButylaMino)-2-oxoethyl)piperidin-4-yl)Methyl)-3-chloro-5-fluorobenzaMide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte